Fairvalue-Calculator Fairvalue-Calculator
EN DE

Medistim ASA (MEDI) Fair Value & Analysis

Healthcare · NO · Market cap 4.2B NOK

Pricekr 235.00
Fair Valuekr 168.01
Upside-28.5%
Quality95/100
Evidence: High Range kr 127.38 – kr 210.99

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Medistim ASA (MEDI) currently trades at kr 235.00, while our model-based Fair Value estimate is kr 168.01 — implying the stock looks roughly 28.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the posi…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Medistim ASA (MEDI) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 168.01 versus a price of kr 235.00 — about −29% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MEDI?
Our 21-model fair value for Medistim ASA is kr 168.01 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 235.00.
What is the quality score of MEDI?
Medistim ASA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.